Liposomal irinotecan in patients with HER2-negative breast cancer and brain metastases: The PHENOMENAL phase 2 study
Year: 2025
Type: article
Language: en
Topic: HER2/EGFR in Cancer Research
Authors and affiliations:
raw_author_name: Manuel Ruiz Borrego
raw_affiliation_strings: Hospital Virgen del Rocío, Sevilla, Spain
raw_author_name: David Páez López-Bravo
raw_affiliation_strings: Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, USA; Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
raw_author_name: Mireia Margelí Vila
raw_affiliation_strings: Medical Oncology Service, Catalan Institute of Oncology, Institut Català d'Oncologia, Germans Trias i Pujol Research Institute, B-ARGO research group, Carretera del Canyet s/n, Badalona 08916, Spain
raw_author_name: José Manuel Pérez-García
raw_affiliation_strings: Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, USA; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain
raw_author_name: María Fernández
raw_affiliation_strings: Hospital Universitario Ramón y Cajal, Universidad de Alcalá de Henares, Madrid, Spain
raw_author_name: Salvador Blanch Tormo
raw_affiliation_strings: Instituto Valenciano de Oncología, Valencia, Spain
raw_author_name: José Ángel García-Saenz
raw_affiliation_strings: Hospital Universitario Clínico San Carlos, Madrid, Spain
raw_author_name: Laura Lema
raw_affiliation_strings: Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain
raw_author_name: Isabel Garau
raw_affiliation_strings: Hospital Son Llàtzer, Palma de Mallorca, Spain
raw_author_name: Patricia Cortez
raw_affiliation_strings: Hospital Ruber Juan Bravo, Universidad Europea, Madrid, Spain
raw_author_name: Antonio Antón Torres
raw_affiliation_strings: Hospital Universitario Miguel Servet, Zaragoza, Spain
raw_author_name: Emilio Alba Conejo
raw_affiliation_strings: Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain
raw_author_name: Isabel Calvo
raw_affiliation_strings: Breast Cancer Unit Oncology, MD Anderson Cancer Center, Madrid, Spain; Fundación MD Anderson Internacional España, Madrid, Spain
raw_author_name: Neus Ferrer
raw_affiliation_strings: Hospital Universitario Son Espases, Palma de Mallorca, Spain
raw_author_name: Isabel Blancas
raw_affiliation_strings: Department of Medicine, Granada University, San Cecilio University Hospital, Granada, Spain; Instituto de Investigación Biosanitaria (IBS), Granada, Spain
raw_author_name: Kepa Amillano
raw_affiliation_strings: Medical Oncology Department, Hospital Universitari Sant Joan de Reus, Reus, Spain
raw_author_name: Sandra Santasusagna
raw_affiliation_strings: Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, USA
raw_author_name: Marc Antoine Benderra
raw_affiliation_strings: Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, USA
raw_author_name: Daniel Alcalá-López
raw_affiliation_strings: Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, USA
raw_author_name: Gabriele Antonarelli
raw_affiliation_strings: Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, National Cancer Institute (IRCCS), Milan, Italy; Department of Oncology and Hemato-Oncology (DIPO), University of Milan, Milan, Italy
raw_author_name: Miguel Sampayo-Cordero
raw_affiliation_strings: Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, USA
raw_author_name: Antonio Llombart-Cussac
raw_affiliation_strings: Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, USA; Hospital Arnau de Vilanova, FISABIO, Valencia, Spain; Translational Oncology Group, Department of Medicine, Facultad de Ciencias de la Salud, Universidad Cardenal Herrera-CEU, Alfara del Patriarca, Spain
raw_author_name: Javier Cortés
raw_affiliation_strings: Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, New Jersey, USA; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine; IOB Madrid, Hospital Beata María Ana; Oncology Department, Hospital Universitario Torrejón, Ribera Group, Madrid, Spain. Electronic address: javier.cortes@maj3.health